BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5406365)

  • 1. Cytoxan as an adjuvant to surgery for lung cancer.
    Higgins GA; Humphrey EW; Hughes FA; Keehn RJ
    J Surg Oncol; 1969; 1(3):221-8. PubMed ID: 5406365
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent therapeutic developments in lung cancer.
    Hansen HH; Selawry OS
    Med Ann Dist Columbia; 1971 Sep; 40(9):580-2. PubMed ID: 4939062
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiotherapy for bronchogenic carcinoma: actual difficulties and plans for the future.
    Dana M
    Cancer Chemother Rep 3; 1973 Mar; 4(2):153-5. PubMed ID: 4734076
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of chemotherapy as an adjuvant to surgery for bronchogenic carcinoma.
    Higgins GA
    Cancer; 1972 Nov; 30(5):1383-7. PubMed ID: 4343295
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of long-term adjuvant chemotherapy with cyclophosphamide (NSC-26271) for radically resected bronchogenic carcinoma.
    Brunner KW; Marthaler T; Müller W
    Cancer Chemother Rep 3; 1973 Mar; 4(2):125-32. PubMed ID: 4199643
    [No Abstract]   [Full Text] [Related]  

  • 6. Some thoughts on surgical adjuvant studies in lung cancer.
    Carter SK
    Cancer Chemother Rep 3; 1973 Mar; 4(2):109-17. PubMed ID: 4729314
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience with combined surgical and cytostatic therapy].
    Schnetzer J
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):200-2. PubMed ID: 5755189
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cancer chemotherapy as a supplement to operation in bronchogenic carcinoma].
    Castberg T; Kruse-Blinkenberg HO
    Ugeskr Laeger; 1976 Jun; 138(24):1449-55. PubMed ID: 1273973
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma.
    Host H
    Cancer Chemother Rep 3; 1973 Mar; 4(2):161-4. PubMed ID: 4729319
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytoxan therapy in the treatment of carcinoma of the lung. (Report of a five-year survival).
    Castro L
    W V Med J; 1974 Jun; 70(6):131-5. PubMed ID: 4524737
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy as an adjunct to surgery in the treatment of pulmonary malignant disease.
    Mountain CF
    Acta Chir Belg; 1971 Apr; 70(4):351-64. PubMed ID: 5143081
    [No Abstract]   [Full Text] [Related]  

  • 12. Lung cancer: perspectives and prospects.
    Ann Intern Med; 1970 Dec; 73(6):1003-24. PubMed ID: 4336754
    [No Abstract]   [Full Text] [Related]  

  • 13. Appraisal of choice and results of treatment for bronchogenic carcinoma.
    Carlens E
    Chest; 1974 Apr; 65(4):442-5. PubMed ID: 4819249
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy-cum-radiotherapy-cum-surgery in the treatment of small-cell bronchogenic carcinoma (author's transl)].
    Gatzemeier U
    Prax Klin Pneumol; 1980 Feb; 34(2):102-7. PubMed ID: 7378158
    [No Abstract]   [Full Text] [Related]  

  • 15. Small-cell bronchogenic carcinoma; advances in treatment.
    Bergevin PR
    N Y State J Med; 1980 Nov; 80(12):1847-50. PubMed ID: 6262689
    [No Abstract]   [Full Text] [Related]  

  • 16. The problem of oat-cell carcinoma.
    Scannell JG
    N Engl J Med; 1970 Jan; 282(2):98-9. PubMed ID: 5409501
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of bronchogenic carcinoma with surgery and radiotherapy: the experience of the National Cancer Institute of Milan.
    Bucalossi P; Ravasi G; Bozzetti F; Milani F
    Cancer Chemother Rep 3; 1973 Mar; 4(2):101-7. PubMed ID: 4729313
    [No Abstract]   [Full Text] [Related]  

  • 18. Bronchogenic carcinoma: nitrogen mustard as a surgical adjuvant and factors influencing survival. University surgical adjuvant lung project.
    Slack NH
    Cancer; 1970 May; 25(5):987-1002. PubMed ID: 4315360
    [No Abstract]   [Full Text] [Related]  

  • 19. [Multimodal treatment in "clinical" non-small cell N2 bronchogenic carcinoma. What is the question?].
    López Encuentra A
    Arch Bronconeumol; 1995 Jan; 31(1):43-4. PubMed ID: 7881720
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical trial of cyclophosphamide (NSC-26271) and radiation therapy for oat cell carcinoma of the lung.
    Tucker RD; Sealy R; van Wyk C; le Roux PL; Soskolne CL
    Cancer Chemother Rep 3; 1973 Mar; 4(2):159-60. PubMed ID: 4354040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.